N@N

Alegro announces update to Board of Directors at annual meeting

^{Published on 2009-06-25 14:24:44, Last Modified on 2009-06-25 14:25:35 - Market Wire}
 

 TORONTO, June 25 /CNW/ - Alegro Health Corp. (TSX-V: AGO), a provider of medical, rehabilitation and disability management services, announced the election of directors following the Company's annual meeting, held this morning at Alegro's corporate offices in Toronto. The board members are as follows: Dr. Martin Barkin, Chairman of the Board, Brenda Rasmussen, President and CEO of Alegro, Robert Wardell, who serves on the Board of several Canadian publicly listed companies and was a Senior Audit Partner with Deloitte & Touche LLP from 1986 to 2006, Tom Magyarody, Director and CEO of the Ontario Dental Association, Dr. Jack Shevel, President of Global Healthcare Investments & Solutions, Inc., and Darren Youngleson, Chief Financial Officer of Global Healthcare Investments & Solutions, Inc. Alegro's largest shareholder. About Alegro Health Corp. Alegro Health Corp. is a leading healthcare services company providing select quality services through its Disability & Rehabilitation Management and Surgical/Hospital Services divisions. Alegro is addressing the growing demand for enhanced insured and uninsured healthcare services, as well as delivering additional resources to Canadian public healthcare services through government outsourcing. With superior knowledge of the healthcare industry, extensive and trusted relationships with payers, physicians, and government agencies, Alegro is pursuing a vertically integrated approach and an aggressive acquisition strategy to achieve its growth objectives. Alegro is listed on the TSX Venture Exchange under the symbol AGO. For further information, please visit[ www.alegrohealth.com ]. This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. These forward-looking statements include, among others, statements regarding business strategy, plans and other expectations, beliefs, goals, objectives, information and statements about possible future events. Specific forward-looking statements contained in this press release include statements regarding Alegro's proposed acquisition of Active Health, the completion of the acquisition and the outcome of the acquisition, as well as statements regarding transaction values, accretion, and ownership levels resulting from the completion of the proposed acquisition. Readers are cautioned not to place undue reliance on such forward-looking statements. Forward-looking statements are based on current expectations, estimates and assumptions that involve a number of risks, which could cause actual results to vary and in some instances to differ materially from those anticipated by Alegro and Active Health and described in the forward-looking statements contained in this press release. Among the various factors that could cause results to vary materially from those indicated in the forward-looking statements include failure to realize anticipated synergies and the result of the review of the proposed acquisition by regulatory authorities. No assurance can be given that any of the events anticipated by the forward-looking statements will transpire or occur or, if any of them do so, what benefits Alegro will derive there from. This release was prepared by management of the Company who takes full responsibility for its contents. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release. %SEDAR: 00016656E 

For further information: Brenda Rasmussen, President and CEO, Alegro Health, (416) 927-8400 ext. 303, [ brasmussen@alegrohealth.com ]; Michael Moore, Investor Relations, Equicom Group, (416) 815-0700 ext. 241, [ mmoore@equicomgroup.com ]